📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents (2017)

First Author: Rajoli R

Attributed to: Towards NanoMedicine Interventions for HIV/AIDS funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40262-017-0557-x

PubMed Identifier: 28540638

Publication URI: http://europepmc.org/abstract/MED/28540638

Type: Journal Article/Review

Parent Publication: Clinical Pharmacokinetics

Issue: 2

ISSN: 0312-5963